Legal Representation
Attorney
Devon E. White
USPTO Deadlines
Next Deadline
167 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-14)
Due Date
January 14, 2026
Grace Period Ends
July 14, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 14, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 14, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 13, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Dec 12, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 18, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 18, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 7, 2019 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 7, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 9, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 14, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 14, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 24, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 11, 2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 10, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 18, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 18, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 18, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 18, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 18, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 15, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 10, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 22, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research services in the areas of cancer and other diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of cancer; Laboratory research services relating to pharmaceuticals; Pharmaceutical research in the field of oncology; Oncology research; Research and development in the biotechnology and oncology fields; Drug testing and discovery services in the field of oncology; product safety testing; Technological research and development relating to the chemical and pharmaceutical industry in the field of oncology; Pharmaceutical product evaluation in the field of cancer treatment drugs; Research and development in the field of personalized medicine and its delivery to patients; Research and development of personalized cancer treatments; Scientific research, development, engineering, testing, and analytical services in the fields of medicine, pharmaceuticals, genetics, and oncology; Biological research, namely, biological sample characterization, screening, and analysis services for scientific research purposes; medical and scientific research in the fields of diseases and diagnosing and treating diseases; Providing medical testing services in the field of cancer research and disease classification; Laboratory testing services, namely, conducting medical tests on biological samples for scientific research purposes; Compiling data for medical and scientific research, clinical trials, and drug admission
First Use Anywhere:
Sep 16, 2019
First Use in Commerce:
Sep 16, 2019
Class 044
Medical services; Clinical and medical laboratory testing services and information for diagnostic purposes in the fields of disease diagnostics and personalized medicine; Consulting services in the field of genetic testing for medical purposes; Consulting services in the field of medical testing for diagnostic purposes; Medical analysis services of patient medical data for the treatment of cancer; Medical services in the field of oncology; Providing personalized drug therapy services for cancer patients; Growing cancer cells in tissue culture and assessing the cells for diagnostic and prognostic purposes; laboratory testing services for medical diagnostic or treatment purposes
First Use Anywhere:
Sep 16, 2019
First Use in Commerce:
Sep 16, 2019
Classification
International Classes
042
044